Promoter analysis of IL-4R gene and its possible associateion of atopic dermatitis

IL-4R基因启动子分析及其与特应性皮炎的可能关系

基本信息

  • 批准号:
    13670897
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

The gene encoding the interleukin-4 receptor alpha chain (IL4R) has received attention as a candidate gene for atopic diseases, and associations have been reported between functionally significant coding polymorphisms of the gene and atopic diseases (Khurana et al. 1997; Mitsuyasu et al. 1998; Oiso et al 2000). Recently, Ober et al. (2000) suggested that the variations outside the coding region of the IL4R gene influence the susceptibility for atopy and asthma. Therefore, we investigated the 5'-flanking region of the gene and identified four new polymorphisms in the IL4R transcriptional promoter: -327A/C, -326C/A, -186A/G, -184A/G. We carried out association study of these polymorphisms in patients with 111 cases of atopic dermatitis versus 82 normal controls. We also recruited 73 patients with psoriasis vulgaris as the second control group. We further investigated more upstream of the 5'-flanking region of the gene and identified two new polymorphisms: -1914T/C and -3223C/T. Frequency of these polymorphisms were examined in 118 patients with atopic dermatitis, 89 normal controls and 70 patients with psoriasis. We found that these polymorphisms have association with atopic dermatitis. Unexpectedly, we also found that four polymorphisms; -327A/C, -326C/A, -186A/G, -184A/G have association with psoriasis as well.
编码白细胞介素-4受体α链(IL 4 R)的基因作为特应性疾病的候选基因受到关注,并且已经报道了该基因的功能上重要的编码多态性与特应性疾病之间的关联(Khurana等,1997; Mitsuyasu等,1998; Oiso等,2000)。最近,Ober等人(2000)提出IL 4 R基因编码区以外的变异影响特应性和哮喘的易感性。因此,我们研究了该基因的5 '侧翼区,并在IL 4 R转录启动子中鉴定了四个新的多态性:-327 A/C,-326 C/A,-186 A/G,-184 A/G。我们对111例特应性皮炎患者和82名正常对照者进行了这些多态性的关联研究。我们还招募了73例寻常型银屑病患者作为第二对照组。我们进一步研究了该基因5 '侧翼区的上游,发现了两个新的多态性:-1914T/C和-3223C/T。检测了118例特应性皮炎患者、89例正常人和70例银屑病患者的多态性频率。我们发现这些多态性与特应性皮炎有关。出乎意料的是,我们还发现了四个多态性:-327 A/C,-326 C/A,-186 A/G,-184 A/G也与银屑病相关。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A. Kato, K. Fukai, N. Oiso, N. Hosomi, T. Murakami, M. Ishii: "Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population"Br J Dermatol. (in press).
A. Kato、K. Fukai、N. Oiso、N. Hosomi、T. Murakami、M. Ishii:“SPINK5 基因多态性与日本人群特应性皮炎的关联”Br J Dermatol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A Kato, K Fukai, et al.: "A novel P gene missense mutation in a Japanese"J Delmatol Sci. (in press).
A Kato、K Fukai 等人:“日本人中的一种新型 P 基因错义突变”J Delmatol Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Karim M, Suzuki K, Fukai,K, Oh J, Nagle DL, Moore K, Barbosa E, Falik-Borenstein T, Filipovich A, Ishida Y, Kivrikko S, Klein C, Kreuz F, Levin A, Miyajima H, Russo C, Uyama E, Vierimaa O, Spritz R: "Apparent genotype-phenotype correlation in 'childhood',
Karim M、铃木 K、Fukai、K、Oh J、Nagle DL、Moore K、Barbosa E、Falik-Borenstein T、Filipovich A、Ishida Y、Kivrikko S、Klein C、Kreuz F、Levin A、Miyajima H、Russo C
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N Oiso, MD, K Fukai, MD, N Hosomi, MD and M Ishii, MD: "Guttate morphoea with Christmas-tree distribution in a patient with human T-cell lymphoma/lymphotropic virus type-1 (HTLV-1) infection"Clin Exp Dermatol. (in press).
N Oiso, MD、K Fukai, MD、N Hosomi, MD 和 M Ishii, MD:“人类 T 细胞淋巴瘤/嗜淋巴细胞病毒 1 型 (HTLV-1) 感染患者的点状硬斑病与圣诞树分布”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Karin M, Suzuki K, Fukai K et al.: "Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome"Am J Med Genuet. 108(1). 16-22 (2002)
Karin M、Suzuki K、Fukai K 等人:“儿童、青少年和成人 Chediak-Higashi 综合征的明显基因型-表型相关性”Am J Med Genuet。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUKAI Kazuyoshi其他文献

FUKAI Kazuyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUKAI Kazuyoshi', 18)}}的其他基金

Mutation analysis of filaggrin gene in Japanese patients with atopic dermatitis
日本特应性皮炎患者丝聚蛋白基因突变分析
  • 批准号:
    19591324
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of methylation status of the promoter of the IRF2 gene, a candidate gene for psoriasis
银屑病候选基因IRF2基因启动子甲基化状态分析
  • 批准号:
    17591180
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoter analysis of the interferon regulatory factor 2 and the SNP analysis of the gene
干扰素调节因子2启动子分析及基因SNP分析
  • 批准号:
    15591187
  • 财政年份:
    2003
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
HPS1 GENE : ITS MUTATION AND FUNCTION
HPS1 基因:其突变和功能
  • 批准号:
    11670846
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cloning of the gene for Chediak-Higashi syndrome
Chediak-Higashi 综合征基因的克隆
  • 批准号:
    09470190
  • 财政年份:
    1997
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

环形RNA在银屑病(psoriasis)干预治疗中的分子机制及潜在应用
  • 批准号:
    32371349
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
  • 批准号:
    MR/Y009657/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Fellowship
Investigating the efficacy and safety profiles of Bimekizumab in treating moderate-to-severe plaque psoriasis: A Canadian retrospective study
调查 Bimekizumab 治疗中重度斑块状银屑病的疗效和安全性:加拿大回顾性研究
  • 批准号:
    484723
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship Programs
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
组织锚定与循环工程酶构建体用于银屑病免疫代谢解决
  • 批准号:
    10667165
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
  • 批准号:
    10820331
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Assessment of Treatment Satisfaction in Psoriasis
银屑病治疗满意度评估
  • 批准号:
    10657012
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Integrative and trans-ethnic study to understand psoriasis associated signals
了解银屑病相关信号的综合和跨种族研究
  • 批准号:
    10657973
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Identification of TARC-producing cells in pustular psoriasis and elucidation of pathogenesis
脓疱型银屑病中 TARC 产生细胞的鉴定及发病机制的阐明
  • 批准号:
    23K07794
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel supersulfide delivery system for the treatment of psoriasis
一种用于治疗牛皮癣的新型超硫化物递送系统
  • 批准号:
    23K17215
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of Novel Topical Therapeutics for Psoriasis
牛皮癣新型局部治疗药物的开发
  • 批准号:
    10698601
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
An investigation of circadian rhythms in psoriasis skin and time-of-day dependent response to ultraviolet B radiation
银屑病皮肤昼夜节律和对紫外线 B 辐射的时间依赖性反应的研究
  • 批准号:
    MR/W02523X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了